Conexiant’s news site is now MDSpire News. Learn more
Advertisement
GC×GC Detective Stories: Biomarkers, Biofuels, and Shape-Shifting Molecules
Philip Marriott, Renée Webster, and Konstantinos Kouremenos revisit three investigations in which an additional dimension of separation provided the information needed to solve three very different analytical mysteries
Clinical Report: GC×GC Detective Stories: Biomarkers, Biofuels, and Shape-Shifting Molecules
Background
The identification of biomarkers for inborn errors of metabolism (IEMs) is crucial for early diagnosis and treatment. Traditional analytical methods often struggle with complex biological matrices, making it difficult to detect specific metabolites. The evolution of analytical techniques, particularly GC×GC, offers enhanced resolution and sensitivity, which is essential for accurate biomarker discovery.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
GC×GC-TOFMS successfully identified crotonylglycine as a novel urinary biomarker for HMGCS2 deficiency.
The biomarker was previously undetectable using one-dimensional GC-MS due to coelution with adipic acid.
Inborn errors of metabolism often result in the accumulation of metabolites that can be detected in urine.
GC-MS remains the reference technique for urinary organic acid analysis due to its ability to handle small, diverse organic acids.
LC-MS/MS is also used in metabolic laboratories, but it has limitations compared to GC-MS.
Clinical Implications
The use of GC×GC can significantly improve the detection of specific biomarkers in newborn screening, potentially leading to earlier diagnosis of metabolic disorders. This advancement underscores the importance of utilizing advanced analytical techniques in clinical laboratories to enhance diagnostic accuracy.
Conclusion
The application of GC×GC in identifying hidden biomarkers represents a significant advancement in the field of metabolic disorder diagnostics. This technique provides a valuable tool for researchers and clinicians in the ongoing effort to improve newborn screening outcomes.